Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Osarogiagbon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer|May 19, 2023
Diagnostic follow-up of indeterminate pulmonary nodules in the Medicare populationPaul F Pinsky, Raymond Osarogiagbon
Microcirculation (New York, N.Y. : 1994)|July 29, 2004
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathyRobert P Hebbel, Raymond Osarogiagbon, Dhananjay Kaul
Chest|December 18, 2022
Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare PopulationPaul Pinsky, Eric Miller, Nick Faris, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2025
Classification of recurrence patterns in surgically treated non-small cell lung cancer - A systematic review and a call for standardizationAlessandro Bonis, Frank Detterbeck, Paula Ugalde Figueroa, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|July 24, 2012
A transition pilot program for adolescents with sickle cell diseaseJane S Hankins, Raymond Osarogiagbon, Patricia Adams-Graves, et al.
JTO Clinical and Research Reports|September 27, 2023
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian PopulationsJohn M Varlotto, Cristina Bosetti, Dwight Bronson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2012
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancerChristelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, et al.
Annals of Internal Medicine|December 15, 2025
Diagnostic Follow-up of Positive Results on Low-Dose Computed Tomography Screening in the Medicare PopulationPaul F Pinsky, Gerard Silvestri, Raymond Osarogiagbon, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2025
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screeningJames L Mulshine, Bruce Pyenson, Cheryl Healton, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2025
AI integrations with lung cancer screening: Considerations in developing AI in a public health settingJames L Mulshine, Ricardo S Avila, Mario Silva, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|May 19, 2023
Diagnostic follow-up of indeterminate pulmonary nodules in the Medicare populationPaul F Pinsky, Raymond Osarogiagbon
Microcirculation (New York, N.Y. : 1994)|July 29, 2004
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathyRobert P Hebbel, Raymond Osarogiagbon, Dhananjay Kaul
Chest|December 18, 2022
Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare PopulationPaul Pinsky, Eric Miller, Nick Faris, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2025
Classification of recurrence patterns in surgically treated non-small cell lung cancer - A systematic review and a call for standardizationAlessandro Bonis, Frank Detterbeck, Paula Ugalde Figueroa, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|July 24, 2012
A transition pilot program for adolescents with sickle cell diseaseJane S Hankins, Raymond Osarogiagbon, Patricia Adams-Graves, et al.
JTO Clinical and Research Reports|September 27, 2023
Meta-Analysis of Rates and Risk Factors for Local Recurrence in Surgically Resected Patients With NSCLC and Differences Between Asian and Non-Asian PopulationsJohn M Varlotto, Cristina Bosetti, Dwight Bronson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2012
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancerChristelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, et al.
Annals of Internal Medicine|December 15, 2025
Diagnostic Follow-up of Positive Results on Low-Dose Computed Tomography Screening in the Medicare PopulationPaul F Pinsky, Gerard Silvestri, Raymond Osarogiagbon, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2025
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screeningJames L Mulshine, Bruce Pyenson, Cheryl Healton, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2025
AI integrations with lung cancer screening: Considerations in developing AI in a public health settingJames L Mulshine, Ricardo S Avila, Mario Silva, et al.
Pageof 1